Lunai Bioworks (LNAI) Convertible Debt (2016 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Convertible Debt of $120000.0 in Q1 2026, down 87.74% quarter-over-quarter from $978495.0 in Q4 2025.
Lunai Bioworks (LNAI) Convertible Debt (2016 - 2026) Analysis & Trends
Lunai Bioworks' Convertible Debt history runs 9 years deep, the most recent figure standing at $120000.0 for Q1 2026.
- In Q1 2026, Convertible Debt changed N/A year-over-year to $120000.0; the TTM figure through Mar 2026 stood at $120000.0 (changed N/A YoY), while the FY2025 annual figure was $245000.0, changed 0.0% from the prior year.
- Convertible Debt was $120000.0 for Q1 2026 at Lunai Bioworks, down from $978495.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $3.7 million in Q1 2024 to a low of $120000.0 in Q1 2026.
- Historically, Convertible Debt has averaged $1.1 million across 5 years, with a median of $1.2 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Convertible Debt tumbled 37.27% in 2023, then soared 208.39% in 2024.
- A 5-year view of Convertible Debt shows it stood at $1.2 million in 2022, then surged by 114.11% to $2.6 million in 2023, then tumbled by 90.46% to $245000.0 in 2024, then soared by 299.39% to $978495.0 in 2025, then sank by 87.74% to $120000.0 in 2026.
- The last three Convertible Debt figures came in at $120000.0 (Q1 2026), $978495.0 (Q4 2025), and $245000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 978,495.00 |
| Sep 30, 2025 | 245,000.00 |
| Jun 30, 2025 | 245,000.00 |
| Jun 30, 2024 | 245,000.00 |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 752,741.00 |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.20 Mn |
| Mar 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | 1.20 Mn |
| Sep 30, 2020 | 1.20 Mn |
| Jun 30, 2020 | 1.20 Mn |